We have pursued several strategies to target AE, for instance, targeting the p300 histone acetyltransferase (HAT) which enables AE to function as an AML-inducing oncogene, with salicylate and diflunisal, to inhibit the growth of AE-expressing leukemia cells47. The gene discussed is TMPRSS11D; the disease is acute myeloid leukemia.